CA Stock MarketDetailed Quotes
BETR BetterLife Pharma Inc
- 0.175
- -0.005-2.78%
15min DelayMarket Closed Jul 5 15:59 ET
21.72MMarket Cap-4069P/E (TTM)
0.180High0.160Low98.53KVolume0.180Open0.180Pre Close16.31KTurnover0.18552wk High0.11%Turnover Ratio124.13MShares0.05052wk Low-0.043EPS TTM16.27MFloat Cap30.000Historical HighLossP/E (Static)92.98MShs Float0.050Historical Low-0.03EPS LYR11.11%Amplitude--Dividend TTM-2.01P/B1Lot Size--Div YieldTTM
BetterLife Pharma Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | (Q3)Oct 31, 2022 | (Q2)Jul 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 195.81%2.27M | -65.33%3.21M | 7.39%730.25K | -83.92%698.62K | -16.16%1.01M | -74.63%766.45K | -7.14%9.26M | -68.10%679.99K | 106.38%4.35M | -64.00%1.21M |
| Selling and administrative expenses | 207.58%2.15M | -59.78%2.64M | 121.14%544.25K | -86.90%565.12K | -7.66%829.78K | -36.47%699.8K | 44.83%6.56M | -83.18%246.11K | 375.39%4.32M | -19.75%898.65K |
| -Selling and marketing expense | ---- | --0 | --0 | --0 | --0 | ---- | -71.85%123.22K | -89.58%16.37K | -56.92%25K | -53.93%26.88K |
| -General and administrative expense | 207.58%2.15M | -59.01%2.64M | 136.90%544.25K | -86.83%565.12K | -4.82%829.78K | -33.14%699.8K | 57.31%6.44M | -82.41%229.74K | 404.91%4.29M | -17.87%871.78K |
| Research and development costs | 72.30%114.83K | -78.67%570.95K | -56.67%186K | 416.00%133.5K | -39.77%184.8K | -96.52%66.65K | -50.61%2.68M | -35.29%429.28K | -97.83%25.87K | -86.28%306.82K |
| Depreciation amortization depletion | ---- | --0 | --0 | --0 | --0 | ---- | -0.01%18.44K | -0.02%4.61K | 0.00%4.61K | 0.00%4.61K |
| -Depreciation and amortization | ---- | --0 | --0 | --0 | --0 | ---- | -0.01%18.44K | -0.02%4.61K | 0.00%4.61K | 0.00%4.61K |
| Operating profit | -195.81%-2.27M | 65.33%-3.21M | -7.39%-730.25K | 83.92%-698.62K | 16.16%-1.01M | 74.63%-766.45K | 7.14%-9.26M | 68.10%-679.99K | -106.38%-4.35M | 64.00%-1.21M |
| Net non-operating interest income (expenses) | -3,710.75%-63.11K | 6.75%-84.95K | -123.98%-70.4K | 65.29%-7.02K | 70.60%-5.87K | 91.50%-1.66K | 92.90%-91.1K | 97.45%-31.43K | -84.68%-20.21K | -20.00%-19.97K |
| Non-operating interest expense | 3,710.75%63.11K | -24.24%50.9K | 383.69%36.35K | -65.29%7.02K | -70.60%5.87K | -91.50%1.66K | 15.14%67.18K | -22.15%7.52K | 84.68%20.21K | 20.00%19.97K |
| Total other finance cost | ---- | 42.37%34.05K | ---- | ---- | ---- | ---- | -98.05%23.92K | ---- | ---- | ---- |
| Other net income (expenses) | 243.72%281.06K | 1,735.28%396.33K | -18.60%107.17K | 257.08%491.9K | -106.84%-7.17K | -473.84%-195.57K | 96.72%-24.24K | 132.43%131.66K | -243.73%-313.16K | 154.73%104.95K |
| Gain on sale of security | 52.52%-136.82K | 15.03%-168.12K | 87.45%98.6K | 74.73%-50.13K | 449.61%71.59K | -812.62%-288.17K | -84.98%-197.85K | 142.40%52.6K | -498.08%-198.4K | -140.84%-20.48K |
| Special income (charges) | --417.88K | 890.21%599.13K | 569.28%599.13K | --0 | --0 | --0 | 119.18%60.51K | -95.40%-127.67K | -213.75%-197.21K | 344.04%150K |
| -Less:Other special charges | ---417.88K | -890.21%-599.13K | ---- | ---- | ---- | ---- | -111.93%-60.51K | -50.33%127.67K | 213.75%197.21K | -344.04%-150K |
| -Gain on sale of property,plant,equipment | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | -130.67%-34.69K | -385.67%-590.56K | 557.47%542.03K | -220.53%-78.76K | 488.75%92.6K | 135.62%113.11K | 195.43%206.73K | 1,574.99%82.44K | 86.38%-24.57K |
| Income before tax | -112.66%-2.05M | 69.08%-2.9M | -19.62%-693.49K | 95.43%-213.74K | 8.66%-1.03M | 67.76%-963.67K | 21.84%-9.37M | 84.63%-579.76K | -111.94%-4.68M | 68.48%-1.13M |
| Income tax | 0 | 0 | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -112.66%-2.05M | 69.08%-2.9M | -19.62%-693.49K | 95.43%-213.74K | 8.66%-1.03M | 67.76%-963.67K | 22.92%-9.37M | 85.28%-579.76K | -111.94%-4.68M | 68.48%-1.13M |
| Net income continuous operations | -112.66%-2.05M | 69.08%-2.9M | -19.62%-693.49K | 95.43%-213.74K | 8.66%-1.03M | 67.76%-963.67K | 22.92%-9.37M | 85.28%-579.76K | -111.94%-4.68M | 68.48%-1.13M |
| Noncontrolling interests | 82.68%-102.5K | 97.34%-9.48K | 1,129.70%609.05K | 95.47%-18.28K | -270.41%-8.31K | -591.94K | -356.57K | 49.53K | -403.85K | -2.24K |
| Net income attributable to the company | -423.71%-1.95M | 67.96%-2.89M | -106.98%-1.3M | 95.43%-195.46K | 9.22%-1.02M | 87.56%-371.73K | 25.85%-9.02M | 84.02%-629.29K | -93.65%-4.28M | 68.54%-1.12M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -423.71%-1.95M | 67.96%-2.89M | -106.98%-1.3M | 95.43%-195.46K | 9.22%-1.02M | 87.56%-371.73K | 25.85%-9.02M | 84.02%-629.29K | -93.65%-4.28M | 68.54%-1.12M |
| Diluted earnings per share | -351.92%-0.0168 | 70.00%-0.03 | -0.01 | 96.54%-0.0017 | 0.00%-0.01 | 90.71%-0.0037 | 37.50%-0.1 | 0 | -66.67%-0.05 | 80.00%-0.01 |
| Basic earnings per share | -351.92%-0.0168 | 70.00%-0.03 | -0.01 | 96.54%-0.0017 | 0.00%-0.01 | 90.71%-0.0037 | 37.50%-0.1 | 0 | -66.67%-0.05 | 80.00%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg